Close Window
You are about to enter the largest, most comprehensive web site dedicated to exposing and ending corruption at Johnson & Johnson and subsidiaries that allows known risky, if not downright harmful, products to reach our healthcare system.
This site has had visitors from the servers of:
(Link to list: Notable Visitors)
- World Health Organization
- National Health Service UK
- US Centers for Disease Control
- Department of Defense
- Department of Justice
- US Federal Reserve

- Ernst & Young
- Group M (world's largest media investment group)
- Young & Rubicam PR FIRM
- Porter Novelli PR FIRM
- Grey Group PR FIRM
- offices of the DOW
- Deutsche Bank
- JPMorgan
- CitiGroup
- The Bank of New York Mellon Corp
- Lloyds Banking Group PLC
- Cantor Fitzgerald & Co.
- Harris Trust & Savings Bank
- BlackRock Financial Management
- The Capital Group
- RBS Securities in US
- Bank of America

- India Institute of Management
- Quinnipiac University
- Universitaet Graz
- Baruch College
- University of North Carolina at Chapel Hill
- University of North Carolina at Greensboro
- Lancaster University
- Yale
- Miami Dade College
- Marymount Manhattan College
- Loyola University
- Punjabi University
- Franciscan University
- Arizona State University
- University of Surrey London
- Loughborough University
- Southern University at New Orleans
- Amrita Vishwa Vidyapeetham University
- Northern Caribbean University
- Louisiana State University
- Hong Kong University of Science and Technology
- Oregon State University
- University of California
- Rutgers University
- Southern New Hampshire University
- Vanderbuilt University
- Macquarie University
- CRI Universite de Nantes - 2 Rue de la Houssiniere
- International Islamic University Of Malaysia
- Baylor University
- Taiwan Academic Network (TANet) Information Center
- Suffolk University
- Pittsburg State University
- Idaho State University
- University of Miami
- University of Hawaii
- University of Colorado
- Duke University
Thank you for your visit,

Content List
100+ articles of harm and corruption by Johnson & Johnson and subsidiary products.
Click for content list...

Mission Statement
Facing another Thanksgiving while homeless and on the streets in absolute desperate poverty. After close to four years of this site, obviously, gifts are few and far between. I hope you'll be one of the few who chooses to send a few dollars to help cover the costs of the work that goes into this site and maybe even enough to get a room to be able to take a shower and sleep in a bed for Thanksgiving.
Thank you for your support to raise awareness of the risks of Johnson & Johnson and subsidiary products and help to get a homeless person out of the nightmare of homelessness,

Expose and end corruption at Johnson & Johnson and subsidiaries to end the onslaught of known risky, if not downright harmful, healthcare products.
Uterine Morcellators
Baby Tylenol
Baby Powder
Contact Lenses
Circular Staplers
Diabetic Glucose Monitors
and more....
Johnson & Johnson Consumer Sales Continue to Drop, 2011 to 2013
Johnson & Johnson consumer goods sales continue to slide in 2013 due to boycotts, recalls and more carcinogens in baby care products.

Keywords: jnj, johnson and johnson, johnson & johnson, J&J, boycott, recall, baby, products
Date Created/Edited: 2013, May 12

Recent Content
The REAL Reason for High Healthcare Product Prices US Senators claim they are investigating the reason for such outrageous drug prices. Uh, gee, not so hard to figure out...
Michelle Obama and the Johnson & Johnson CEO Gorsky $5 Billion Risperdal, Omnicare, Medicaid Scandal Hey-uh, when Johnson & Johnson Janssen was illegally funneling money out of Medicaid through Omnicare for Risperdal - Uh, Michelle was HOSPITAL ADMINISTRATOR in Chicago, where original case broke.
How Johnson & Johnson is Screwing Their Institutional Shareholders Multiply number of shares by $3. Subtract 50% of foreclosure losses, 60% of bankruptcies, percentage of loan defaults due to injuries caused by a Johnson & Johnson or subsidiary product. Hm. Probably looks like Johnson & Johnson crappy products are costing your financial instituation a LOT of money ;o)
Risperdal US DEATH Warning for Elderly Dementia NOT Applied in AU Q to Alex Gorsky, Chairman/CEO of Johnson and Johnson, would you give your USA banned drug Risperdal to your father, if he had dementia?
United States Senate HELPless Committee The US Senate Committee on Health, Education, Labor and Pensions is supposed to be looking out for best interest of voters, but seems to be taking cash from BOTH sides and protecting corruption at Johnson & Johnson and Obama administration.
List of Interesting Visitors to the Johnson and Toxin web site (colleges, universities, law firms, journalists, financial institutions,...)
Please read:
2015 Consumer Letter to Johnson & Johnson Shareholders
Honoring Request to Say Something Nice About Johnson & Johnson
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500.
Numerous groups have called for boycotts of Johnson & Johnson products for a variety of reasons. In addition, as more mothers in the United States are educated regarding known carcinogens in the U.S. formulation of baby soap, shampoo, powder, lotions, creams and other baby products as well as the same carcinogens in adult care products, it is obvious that the sales of J&J toxic consumer products are suffering as consumers choose less toxic products.
2011 : 2011 consumer sales : U.S. decrease 6.7% / Int increase 7.3 / WW increase 2.0%
http://www.investor.jnj.com/2011annualreport/pdf/JNJ-2011_ManagementsDiscussion_AnalysisSales.pdf page 2 of 11
2012 : 1st quarter consumer sales : U.S. decrease 2.2% / Int decrease 2.5% / WW decrease 2.4%
Worldwide Consumer sales of $3.6 billion for the first quarter represented a decrease of 2.4% versus the prior year consisting of an operational decline of 0.6% and a negative impact from currency of 1.8%. Domestic sales decreased 2.2%. International sales decreased 2.5%, which reflected an operational increase of 0.4% and a negative currency impact of 2.9%.
2012 : 2nd quarter consumer sales : U.S. decrease 1.9% / Int decrease 6.0% / WW decrease 4.6%
Worldwide Consumer sales of $3.6 billion for the second quarter represented a decrease of 4.6% versus the prior year consisting of an operational increase of 0.6% and a negative impact from currency of 5.2%. Domestic sales decreased 1.9%. International sales decreased 6.0%, which reflected an operational increase of 2.0% and a negative currency impact of 8.0%.

2012 : 3rd quarter consumer sales : U.S. decrease 4.3% / Int decrease 6.1% / WW decrease 4.3%
Worldwide Consumer sales of $3.6 billion for the third quarter represented a decrease of 4.3% versus the prior year consisting of an operational increase of 1.0% and a negative impact from currency of 5.3%. Domestic sales decreased 0.4%. International sales decreased 6.1%, which reflected an operational increase of 1.8% and a negative currency impact of 7.9%.
2012 : full year consumer sales : U.S. decrease 2% / Int decrease 3.4% / WW decrease 2.9%
Worldwide Consumer sales of $14.4 billion for the full-year 2012 represented a decrease of 2.9% versus the prior year, consisting of an operational increase of 0.5% and a negative impact from currency of 3.4%. Domestic sales decreased 2.0%; international sales decreased 3.4%, which reflected an operational increase of 1.9% and a negative currency impact of 5.3%.
With yet another recall of Children's Tylenol and yet another undisclosed carcinogen found in yet another baby care product, I don't see Johnson & Johnson consumer sales rebounding any time soon. I don't know, maybe people don't want to risk using products on their children that might harm their precious babies. As people like me continue sharing the risks as fast as we can with other moms so they don't use toxic products, I think sales will likely continue to drop.
Something to consider: As fewer people use toxic products from Johnson & Johnson, the rate of long-term illnesses, such as asthma, allergies, chronic sinus infections, COPD, cancer, low fertility, and such, caused by these products (and the drugs prescribed to deal with side effects of the drugs prescribed) will begin to decline - cutting into Johnson & Johnson medical devices and pharmaceuticals sales ;o)
1. Elizabeth Lopatto (2013, May 3). J&J Recalls Some Children’s Tylenol in South Korea Bloomberg. Retrieved from http://www.bloomberg.com/news/2013-05-03/j-j-recalls-some-children-s-tylenol-in-south-korea.html
2. Ganesh N (2013, April 25). FDA suspends J&J Licence New indian Express. Retrieved from http://www.newindianexpress.com/nation/FDA-suspends-JJ-Licence/2013/04/25/article1560077.ece
All contents Copyright © 2012-2015 Emily Patterson / Johnson and Toxin. All rights reserved.
Web Site and Admin Info:
Privacy Policy
Site Statistics
Site Resources
Financial Disclosure

Recently Posted:
2015 Johnson & Johnson US Lawsuit Update: Jump from 48,500 to 56.500
Johnson & Johnson Plans to Expand Healthcare Cost Crisis and Product Liability in Asia
Who REALLY Pays for Drug Development? US TAXPAYERS - $21 BILLION for fiscal year 2014
Johnson & Johnson Janssen Xarelto Marketed In Violation of FDA Regulations
Johnson & Johnson Destroys Thousands of Files Related to Vaginal Mesh
Johnson & Johnson: The Global Lawsuit Company

Most Popular:
The Ever-Growing Number of Lawsuits Against Johnson & Johnson
Johnson & Johnson Credo Analysis
Johnson & Johnson $4 Billion for DePuy Hip Harm in U.S., With Lawsuits in at Least 4 More Countries